248 related articles for article (PubMed ID: 28760631)
41. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Guo J; Seo Y; Ren S; Hong S; Lee D; Kim S; Jiang Y
Abdom Radiol (NY); 2016 Oct; 41(10):1960-72. PubMed ID: 27318936
[TBL] [Abstract][Full Text] [Related]
43. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S
Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142
[TBL] [Abstract][Full Text] [Related]
44. Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis.
Schulz A; Dormagen JB; Drolsum A; Bjørnbeth BA; Labori KJ; Kløw NE
Acta Radiol; 2012 Dec; 53(10):1081-7. PubMed ID: 23081954
[TBL] [Abstract][Full Text] [Related]
45. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
[TBL] [Abstract][Full Text] [Related]
46. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation.
Albrecht MH; Wichmann JL; Müller C; Schreckenbach T; Sakthibalan S; Hammerstingl R; Bechstein WO; Zangos S; Ackermann H; Vogl TJ
Eur J Radiol; 2014 Oct; 83(10):1752-8. PubMed ID: 25082480
[TBL] [Abstract][Full Text] [Related]
47. The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.
Karagkounis G; Cai G; Johnson PT; Pawlik TM; Fishman EK; Choti MA
Ann Surg Oncol; 2015 Jul; 22(7):2201-8. PubMed ID: 25582736
[TBL] [Abstract][Full Text] [Related]
48. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
49. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
[TBL] [Abstract][Full Text] [Related]
50. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study.
Wang JH; Chen TY; Ou HY; Wang CC; Liu YW; Hung CH; Chen CH; Kuo CH; Hu TH; Cheng YF; Lu SN
Dig Dis Sci; 2016 Apr; 61(4):1197-205. PubMed ID: 26668057
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of Efficiencies on the Gadoxetic Acid-enhanced MRI for Preoperative Assessment of Liver Metastases from Colorectal Carcinoma].
Iwata K; Moriya T; Nakagawa S; Ogasawara K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(1):29-38. PubMed ID: 29353834
[TBL] [Abstract][Full Text] [Related]
52. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE
Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901
[TBL] [Abstract][Full Text] [Related]
54. Accuracy of multislice liver CT and MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy.
van Kessel CS; van Leeuwen MS; van den Bosch MA; Borel Rinkes IH; Mali WP; Westers P; van Hillegersberg R
Dig Surg; 2011; 28(1):36-43. PubMed ID: 21293130
[TBL] [Abstract][Full Text] [Related]
55. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
56. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
[TBL] [Abstract][Full Text] [Related]
57. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
[TBL] [Abstract][Full Text] [Related]
58. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
[TBL] [Abstract][Full Text] [Related]
59. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.
Zech CJ; Korpraphong P; Huppertz A; Denecke T; Kim MJ; Tanomkiat W; Jonas E; Ba-Ssalamah A;
Br J Surg; 2014 May; 101(6):613-21. PubMed ID: 24652690
[TBL] [Abstract][Full Text] [Related]
60. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer.
Hwang JA; Kim YK; Min JH; Song KD; Sohn I; Ahn HS
Acta Radiol; 2019 Apr; 60(4):441-450. PubMed ID: 30130970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
